ATE48231T1 - Makromolekulare cdp-cholinderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel. - Google Patents

Makromolekulare cdp-cholinderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel.

Info

Publication number
ATE48231T1
ATE48231T1 AT86113539T AT86113539T ATE48231T1 AT E48231 T1 ATE48231 T1 AT E48231T1 AT 86113539 T AT86113539 T AT 86113539T AT 86113539 T AT86113539 T AT 86113539T AT E48231 T1 ATE48231 T1 AT E48231T1
Authority
AT
Austria
Prior art keywords
cdp
choline
macromolecular
processes
production
Prior art date
Application number
AT86113539T
Other languages
English (en)
Inventor
Vincenzo Zappia
Rosa Mario De
Original Assignee
Vincenzo Zappia
Rosa Mario De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincenzo Zappia, Rosa Mario De filed Critical Vincenzo Zappia
Application granted granted Critical
Publication of ATE48231T1 publication Critical patent/ATE48231T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT86113539T 1985-10-01 1986-10-01 Makromolekulare cdp-cholinderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel. ATE48231T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22327/85A IT1201474B (it) 1985-10-01 1985-10-01 Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
EP86113539A EP0218190B1 (de) 1985-10-01 1986-10-01 Makromolekulare CDP-Cholinderivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE48231T1 true ATE48231T1 (de) 1989-12-15

Family

ID=11194722

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86113539T ATE48231T1 (de) 1985-10-01 1986-10-01 Makromolekulare cdp-cholinderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel.

Country Status (8)

Country Link
US (1) US4772463A (de)
EP (1) EP0218190B1 (de)
JP (1) JPS62129296A (de)
AT (1) ATE48231T1 (de)
DE (1) DE3667139D1 (de)
ES (1) ES2011767B3 (de)
GR (1) GR3000235T3 (de)
IT (1) IT1201474B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE105479T1 (de) * 1988-10-27 1994-05-15 Massachusetts Inst Technology Verfahren zur steigerung des phosphatidylcholins in vivo.
CA2072072A1 (en) * 1990-10-24 1992-04-25 Masayuki Kuzuya Organic polymer compound and production thereof
CA2316989A1 (en) * 1997-12-24 1999-07-08 Interneuron Pharmaceuticals, Inc. Hyperhydrated citicoline, process and use
AU2001247474A1 (en) 2000-03-16 2001-09-24 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
US7053064B2 (en) 2002-11-08 2006-05-30 The Mclean Hospital Corporation Compounds for the treatment of tobacco dependence and withdrawal
WO2005122767A1 (en) 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
EP1784199A4 (de) 2004-08-11 2010-06-23 Mclean Hospital Corp Verbindungen zur behandlung von marihuana-abhängigkeit, entzug und konsum
CN103509073B (zh) * 2013-08-29 2016-01-06 洪军 一种胞磷胆碱钠化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2402664A1 (fr) * 1977-09-07 1979-04-06 Agronomique Inst Nat Rech Produits de couplage phosphorylcholine, composes amines procede d'obtention et applications
IT1207106B (it) * 1980-04-18 1989-05-17 Made Italiana Srl Ora Searle I Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Also Published As

Publication number Publication date
EP0218190A3 (en) 1987-09-30
GR3000235T3 (en) 1991-03-15
EP0218190A2 (de) 1987-04-15
IT8522327A0 (it) 1985-10-01
US4772463A (en) 1988-09-20
JPS62129296A (ja) 1987-06-11
EP0218190B1 (de) 1989-11-29
IT1201474B (it) 1989-02-02
DE3667139D1 (de) 1990-01-04
ES2011767B3 (es) 1990-02-16

Similar Documents

Publication Publication Date Title
DK160881C (da) Interpolymer indeholdende indpolymeriserede enheder af acrylsyre, hvis carboxylgrupper er delvis neutraliseret, og af alkylacrylat eller -methacrylat med henholdsvis hoejere og lavere alkylgrupper samt formet genstand omfattende en saadan polymer
KR960703956A (ko) 아크릴릭-포화 고무 하이브리드 감압 접착제
BR9715021A (pt) Polìmeros sensìveis à temperatura e produtos dispersos em água contendo polìmeros
ATE46913T1 (de) Verfahren zur diskontinuierlichen herstellung von vernetzten, feinteiligen polymerisaten.
DE69615833D1 (de) Klebriggemachte segmentierte polydiorganosiloxan-oligoharnstoff-copolymere sowie verfahren zu deren herstellung
BR9713972A (pt) Processo para preparar acrilatos e metacrilatos poliméricos reticuláveis por radiação
BR9815112B1 (pt) processo para a preparaÇço de polÍmeros sintÉticos com teor de monâmero residual muito baixo.
DE69033994D1 (de) Flüssige Polymerzusammensetzung und Verfahren zu ihrer Verwendung
ATE1589T1 (de) Verwendung von (meth)acrylsaeure-maleinsaeurecopolymerisatenals inkrustierungsinhibitoren in waschmitteln.
FR2700549B1 (fr) Procédé de préparation de polymères amine-aldéhyde contenant des groupes sulfo, polymères obtenus selon ce procédé et leur utilisation.
ATE48231T1 (de) Makromolekulare cdp-cholinderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel.
ATE31069T1 (de) Wasserloesliche terpolymere, verfahren zu deren herstellung und verwendung als klebstoff.
DE3869147D1 (de) Copolymer von vinylidenfluorid-acrylsaeureester, verfahren zu dessen herstellung und dieses enthaltende zusammensetzung.
DK0999736T3 (da) Aftagelig beskyttelsesbelægning
FR2704752B1 (fr) Composition cosmétique sous forme de gel aqueux.
NZ217231A (en) Sustained release composition containing propionic acid derivative and acrylic, then methacrylic, acid polymer and copolymer coatings
ES2019088B3 (es) Dispersion acuosa de un polimero de adicion, una composicion de recubrimiento basada en ella y un procedimiento para recubrir un sustrato con dicha composicion de recubrimiento.
ATE90198T1 (de) Hautschutzmittel.
BR8405886A (pt) Processo e composicoes referentes a ativacao de agentes branqueadores fluorescentes
ES469830A1 (es) Matriz de polimero basada en acrilamida.
ATE296322T1 (de) Zusammensetzung
DE3789910D1 (de) Strahlenhärtbare Harzzusammensetzung.
BR9106554A (pt) Processo de aumentar o efeito de uma polissacarideo hidrolase,processo enzimatico que usa uma polissacarideo hidrolase,preparacao de polissacarideo hidrolase,preparacao de endo-glucanase,preparacao de pululanase mista,preparacao de pululanase mista,e,composicao detergente
FR2738841B1 (fr) Procede de polymerisation de sequences d'acides nucleiques et ses applications
ES2001661A6 (es) Adhesivos y obturadores acrilicos con resistencia en caliente mejorada.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee